Inclusion criteria: |
•Age (years): 18–75 |
•Histologically confirmed rectal cancer |
•Clinical stage: cTxN1-2M0 or cT3-4N0M0 |
•Suspicion of LLN metastasis: short-axis diameter of lateral lymph nodes (LLN) >5 mm; short diameter of common iliac or external iliac lymph nodes >6 mm [16, 24, 25] |
•No extramesorectal lymph node swelling (short-axis diameter <10 mm) |
•No invasion of other organs |
•Performance Status (PS): 0, 1 |
•No past history of chemotherapy, pelvic surgery, or radiation |
•Written informed consent operative criteria: |
•Mesorectal excision is performed |
•Operative findings: |
Main lesion of the tumor is located at the rectum |
Lower tumor margin is below the peritoneal reflection |
Stage R0 after resection |
Exclusion criteria: |
•High rectal cancer: lower tumor margin is above the peritoneal reflection |
•Multiple-cancer patients |
•Pregnant patients |
•Patients with psychological disorder |
•Steroid administration |
•Cardiac infarction within previous 6 months |
•Severe pulmonary emphysema and/or pulmonary fibrosis |
•Physician’s decision to exclude |
•Patients with confirmed LLN metastasis: short-axis diameter of LLN >10 mm and a lymph node with an irregular edge, heterogeneous signal, or obvious enlargement and after nCRT has been completed, lymph node enlarges more than 30% |
•Emergency surgery |
•Patients with coagulopathies |